VIRVir Biotechnology, Inc.Nov 4, 2026Q3 2026
Read transcript →Vir Biotechnology, Inc. (VIR) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$13.96
+13.27%
Mkt Cap $1.91B
VIRVir Biotechnology, Inc.Nov 4, 2026VIRVir Biotechnology, Inc.Aug 5, 2026Q2 2026
Read transcript →VIRVir Biotechnology, Inc.May 6, 2026Q1 2026
Read transcript →VIRVir Biotechnology, Inc.Feb 24, 2026Q4 2025
Read transcript →VIRVir Biotechnology, Inc.Nov 5, 2025Q3 2025
Read transcript →VIRVir Biotechnology, Inc.Aug 6, 2025Q2 2025
Read transcript →VIRVir Biotechnology, Inc.May 7, 2025Q1 2025
Read transcript →VIRVir Biotechnology, Inc.Feb 26, 2025Q4 2024
Read transcript →VIRVir Biotechnology, Inc.Oct 31, 2024Q3 2024
Read transcript →VIRVir Biotechnology, Inc.Aug 1, 2024Q2 2024
Read transcript →VIRVir Biotechnology, Inc.May 2, 2024Q1 2024
Read transcript →VIRVir Biotechnology, Inc.Feb 22, 2024Q4 2023
Read transcript →VIRVir Biotechnology, Inc.Nov 2, 2023Q3 2023
Read transcript →VIRVir Biotechnology, Inc.Aug 3, 2023Q2 2023
Read transcript →